Forecast: Basic Pharmaceutical Products Production Value in the UK

From 2013 to 2023, the UK's basic pharmaceutical products production value has seen considerable fluctuation. The peak was in 2013 at 6.85 billion euros, followed by a significant drop in 2014 to 1.65 billion euros, a decrease of 75.87%. The subsequent years showed smaller variations with a general decreasing trend, reaching 1.39 billion euros in 2023. The annual variation over the last two years was -6.43% in 2023 and -14.69% in 2022. The CAGR for the past five years is -6.62%.

Looking forward to the forecasted data from 2024 to 2028, the production value is expected to continue its downward trend, reaching approximately 0.898 billion euros by 2028. This represents a forecasted 5-year CAGR of -7.03% and an overall decline of 30.55% by 2028.

Future trends to watch for:

• Emergence of biosimilars and their impact on production value
• Increased investment in biopharmaceutical innovations
• Potential regulatory changes post-Brexit affecting manufacturing and exports
• Potential shifts in global supply chain dependencies